All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Antimicrobial effect of salicylamide derivatives against intestinal sulfate-reducing bacteria

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216275%3A25310%2F16%3A39901615" target="_blank" >RIV/00216275:25310/16:39901615 - isvavai.cz</a>

  • Alternative codes found

    RIV/62157124:16370/16:43874210

  • Result on the web

    <a href="http://dx.doi.org/10.1016/j.jab.2016.01.005" target="_blank" >http://dx.doi.org/10.1016/j.jab.2016.01.005</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1016/j.jab.2016.01.005" target="_blank" >10.1016/j.jab.2016.01.005</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Antimicrobial effect of salicylamide derivatives against intestinal sulfate-reducing bacteria

  • Original language description

    Sulfate-reducing bacteria (SRB) are most likely involved in both the initiation and maintenance of inflammatory bowel disease (IBD); unfortunately present antibacterial chemotherapeutics used in the treatment of IBD have been ineffective. Thus, the antimicrobial activity of salicylamide derivatives against two different genera of intestinal SRB, Desulfovibrio and Desulfomicrobium, was investigated. Six 2-(phenylcarbamoyl) phenyl N-[(benzyloxy)carbonyl] alkanoates and three 2-hydroxy-N-[(2S)-1-oxo-1-(phenylamino)alkan-2-yl]benzamides showed MIC values in the range from 0.22 to 0.35 mu M against Desulfovibrio piger Vib-7 and in the range from 0.27 to 8.52 mu M against Desulfomicrobium sp. Rod-9, while MIC values of ciprofloxacin were 41.2 mu M and 39.3 mu M. The highest potency against the two strains was observed for 4-chloro-N-{(2S)-1-[(3,4-dichlorophenyl)amino]-3-methyl-1-oxobutan-2-yl}-2-hydroxybenzamide (MIC 0.22 mu M and 0.27 mu M). 4-Chloro-2-[(4-nitrophenyl) carbamoyl]phenyl (2S)-2-{[(benzyloxy)carbonyl]amino}-3-methylbutanoate showed high activity against D. piger Vib-7 (MIC = 0.26 mu M), while 4-chloro-2-[(4-methylphenyl)carbamoyl]phenyl (2S)-2-[( tert-butoxycarbonyl)amino]-3-(1H-indol-2-yl) propanoate expressed high activity against Desulfomicrobium sp. Rod-9 (MIC = 0.31 mu M). Structure-activity relationships are discussed.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

  • CEP classification

    CC - Organic chemistry

  • OECD FORD branch

Result continuities

  • Project

    <a href="/en/project/EE2.3.30.0053" target="_blank" >EE2.3.30.0053: Pharmaco-toxicological evaluation of newly synthesized (isolated) compounds as an integration tool for pre-clinical disciplines at VFU Brno</a><br>

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2016

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Journal of Applied Biomedicine

  • ISSN

    1214-021X

  • e-ISSN

  • Volume of the periodical

    14

  • Issue of the periodical within the volume

    2

  • Country of publishing house

    CZ - CZECH REPUBLIC

  • Number of pages

    6

  • Pages from-to

    125-130

  • UT code for WoS article

    000373608500007

  • EID of the result in the Scopus database